ORKA
Oruka Therapeutics Inc.

206
Mkt Cap
$1.46B
Volume
342,612.00
52W High
$32.28
52W Low
$5.49
PE Ratio
-12.50
ORKA Fundamentals
Price
$30.32
Prev Close
$30.21
Open
$30.22
50D MA
$27.38
Beta
0.98
Avg. Volume
452,976.05
EPS (Annual)
-$4.99
P/B
3.02
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight research firms that are currently covering the company...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Reaches New 12-Month High - Should You Buy?
Oruka Therapeutics (NASDAQ:ORKA) Reaches New 1-Year High - Time to Buy...
MarketBeat·2d ago
News Placeholder
Oruka Therapeutics, Inc. $ORKA Shares Purchased by Geode Capital Management LLC
Geode Capital Management LLC boosted its position in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 100.6% in the second quarter, according to the company in its most recent filing...
MarketBeat·6d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week High - What's Next?
Oruka Therapeutics (NASDAQ:ORKA) Hits New 12-Month High - Time to Buy...
MarketBeat·7d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 6.9% - Here's Why
Oruka Therapeutics (NASDAQ:ORKA) Trading Down 6.9% - What's Next...
MarketBeat·13d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Reaches New 1-Year High - Here's What Happened
Oruka Therapeutics (NASDAQ:ORKA) Hits New 12-Month High - Time to Buy...
MarketBeat·17d ago
News Placeholder
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Rating of "Moderate Buy" by Analysts
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight research firms that are presently covering the stock, Marketbeat.com...
MarketBeat·25d ago
News Placeholder
Research Analysts Issue Forecasts for ORKA FY2025 Earnings
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) - Investment analysts at Wedbush decreased their FY2025 earnings per share (EPS) estimates for Oruka Therapeutics in a report issued on Thursday...
MarketBeat·25d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen downgraded Oruka Therapeutics from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·27d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $63.00 at BTIG Research
BTIG Research lifted their price target on Oruka Therapeutics from $56.00 to $63.00 and gave the stock a "buy" rating in a report on Thursday...
MarketBeat·28d ago

Latest ORKA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.